Results 141 to 150 of about 34,847 (196)

Recent Progress in the Synthesis, Functionalization, and Biological Outlook of Pyrimidines. [PDF]

ACS Omega
Martis GJ, Mugali PS, Gaonkar SL.
europepmc   +1 more source

Design, Synthesis, <i>In Vitro</i> Evaluation, Multitargeted Molecular Docking, and <i>In Silico</i> Analysis of Some Azo-Linked 1,3,4-Thiadiazole and 1,2,4-Triazole Heterocyclic Hybrids as Potent Antitubercular Agents. [PDF]

ACS Omega
Panigrahi D, Sahu SK.
europepmc   +1 more source

Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives. [PDF]

RSC Adv
Rakshit G, Chakraborty S, Bhakta S, Jayaprakash V.   +3 more
europepmc   +1 more source

Tuberculosis-associated immune reconstitution inflammatory syndrome in a non-immunocompromised patient. [PDF]

Breathe (Sheff)
Angelopoulos V, Papanikolaou A, Chronis C, Kyriakopoulos C, Ladias A, Assioura A, Gogali A, Kostikas K, Salla E.   +8 more
europepmc   +1 more source

First episode of psychosis in a patient undergoing tuberculosis treatment. [PDF]

Breathe (Sheff)
Murray J, Dolan L, MacKenna C, Cooney J, Keane J, McLaughlin AM.   +5 more
europepmc   +1 more source

Thiadiazole-azetidinone sulfonamide hybrids with antimycobacterial activity supported by structure-based analysis. [PDF]

RSC Adv
Vishwakarma SK, Mishra A, Panigrahi N, Roque-Borda CA.   +3 more
europepmc   +1 more source

Isoniazid-Derived Hydrazones Featuring Piperazine/Piperidine Rings: Design, Synthesis, and Investigation of Antitubercular Activity. [PDF]

Biomolecules
Özcan E, Vagolu SK, Tamhaev R, Lherbet C, Mourey L, Tønjum T, Gündüz MG, Doğan ŞD.   +7 more
europepmc   +1 more source

Old Pathogens-New Patient Types: Infections in a CAR T-Cell Recipient. Could It Get Any More Complicated? [PDF]

Transpl Infect Dis
Melchio M, Hill JA, Shah M, Neofytos D, Gambella M, Raiola AM, Delfino E, Balletto E, Angelucci E, Bassetti M, Mikulska M.   +10 more
europepmc   +1 more source